UK's MHRA revokes authorisation for Novartis' sickle cell drug
UK News: Britain's health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis' sickle cell disease drug, Adakveo.
Source: indiatimes.com
Conditional Marketing Authorisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Conditional Marketing Authorisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Conditional Marketing Authorisation Today - Breaking & Trending Today
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mirati Therapeutics, Inc.
NEW YORK, Aug. 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. . Such investors are advised to contact Robert S. Willoughby... -Today at 02:13 pm- MarketScreener
Source: marketscreener.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mirati Therapeutics, Inc.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. ("Mirati" or the "Company") (NASDAQ: MRTX). Such...
Source: prnewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mirati Therapeutics, Inc.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. ("Mirati" or the "Company") (NASDAQ: MRTX). Such...
Source: prnewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mirati Therapeutics, Inc.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. ("Mirati" or the "Company") (NASDAQ: MRTX). Such...
Source: prnewswire.com